Pharmacovigilance ASIA Congress 2021

Pre - Register for

 Pharmacovigilance ASIA Congress 2021

visit www.gravitoninternational.com for updates

Speaker Proposals are Invited.

Email your abstracts / proposals to pharmacovigilance@gravitonevents.org

----------------------------------------------------------

The conference will bring together industry experts and regulators to discuss the new updates in legislation, operational challenges of implication of these changes, experience of implementing global risk management plans, the best and effective way forward, impact of IT and social media on PV and harmonization of different regulatory bodies.

Key Themes

• Explore the impact of PV legislation changes and updates on industries and the best practices
• Assuring Compliance and its monitoring
• Preparing for PV audit and inspections and the role of QPPV
• Risk management plans, strategies and new risk- benefit analysis tools to improve REMS reporting
• Implementing risk management and safety surveillance methodologies for medical devices
• New approaches for risk minimization and communication
• Determining steps and strategies for more transparency and involvement of patients
• Discussing the how IT and Social media effect Pharmacovigilance and Adverse events reporting
• Discuss and review the use of databases and emerging tools for generation and detection of safety signals
• Importance of outsourcing and its effectiveness
• Harmonization of regulatory framework- developed and emerging markets

Why Should You Attend

Pharma/BioTech companies are always faced with the challenge to improve quality of the safety data with the ever-increasing quantity of the data. The companies are also left with the challenge to manage the dynamic regulatory requirements. There are still many complexities that the industries and the regulatory authorities have to tackle. With more communication and networking you can expand your knowledge on the key complications currently experienced by various industries and departments and design new strategies to overcome the same.

Who Should Attend

VPs, Directors, Heads, Managers, Scientific Advisors, Consultants, Research Scholars and professionals with intermediate to advance knowledge and experience in the following

• Pharmacovigilance
• Risk management
• Drug safety
• Pharmacoepidemiology
• Drug Research & Development
• Clinical Pharmacology
• Clinical Safety
• Information and Clinical Data Management
• Medical product safety assessment
• Clinical research & safety
• Data analysis
• Information technology
• Medical information
• Health outcomes
• Sales and Marketing
• CRO’s
• Contract Manufacturing

*Graviton International Terms and Conditions (T&C) applicable.